PetMed Express, Inc. reported a significant decline in financial performance for the third quarter of fiscal 2026, ending December 31, 2025. The company recorded net sales of $40.7 million, a decrease of 21.7% from $52.0 million in the same quarter of the previous year. For the nine months ended December 31, 2025, total sales were $136.2 million, down 22.7% from $176.2 million in the prior year. The decline was primarily attributed to reduced prescription medication sales and increased consumer promotional usage, which negatively impacted reorder and new order sales.
The company's gross profit also suffered, falling to $9.5 million for the quarter, a 41.4% decrease from $16.1 million year-over-year. The gross margin percentage dropped to 23.3% from 31.0%, reflecting the impact of a $2.1 million inventory write-down and higher promotional costs. Operating expenses surged, with general and administrative costs increasing by 13.1% to $12.2 million for the quarter, driven by higher professional fees and stock-based compensation. The company reported a net loss of $10.6 million, compared to a loss of $0.7 million in the same quarter of the previous year.
In terms of operational metrics, PetMed Express acquired approximately 59,000 new customers during the quarter, a decrease from 63,000 in the prior year. The average purchase per customer remained stable at around $97. The company also noted that recurring net sales, which include AutoShip subscriptions and membership-related revenue, accounted for 61.5% of total gross sales, up from 56.2% in the previous year.
Looking ahead, PetMed Express faces challenges due to increased competition and changing consumer behavior influenced by macroeconomic factors such as inflation and rising interest rates. The company has suspended its quarterly dividend to focus on growth initiatives and is currently evaluating unsolicited acquisition proposals ranging from $4 to $4.25 per share. Management remains cautious about future sales growth, emphasizing the need to adapt to evolving market conditions.
About PETMED EXPRESS INC
PetMed Express, Inc. is a leading direct-to-consumer pet pharmacy offering prescription and non-prescription medications, food, supplements, and supplies for dogs, cats, and horses. Through its brands PetMeds and PetCareRx, it provides online sales, telehealth, pet insurance, and veterinary partnerships across North America. The company emphasizes quality, regulatory compliance, customer support, and innovative digital platforms to serve pet owners and promote pet wellness.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.